PetMed Express (Nasdaq: PETS) reported earnings on Oct. 22. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q2), PetMed Express beat slightly on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue was unchanged and GAAP earnings per share expanded.

Gross margins dropped, operating margins expanded, net margins increased.

Revenue details
 PetMed Express reported revenue of $58.1 million. The seven analysts polled by S&P Capital IQ predicted sales of $57.2 million on the same basis. GAAP reported sales were 0.1% lower than the prior-year quarter's $58.2 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.20. The six earnings estimates compiled by S&P Capital IQ anticipated $0.17 per share. GAAP EPS of $0.20 for Q2 were 5.3% higher than the prior-year quarter's $0.19 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 33.3%, 90 basis points worse than the prior-year quarter. Operating margin was 10.9%, 50 basis points better than the prior-year quarter. Net margin was 6.9%, 20 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $47.9 million. On the bottom line, the average EPS estimate is $0.16.

Next year's average estimate for revenue is $229.1 million. The average EPS estimate is $0.72.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 875 members out of 904 rating the stock outperform, and 29 members rating it underperform. Among 208 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 199 give PetMed Express a green thumbs-up, and nine give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on PetMed Express is hold, with an average price target of $9.50.

Can your portfolio provide you with enough income to last through retirement? You'll need more than PetMed Express. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.